Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)

Clinical trial NCT01259856 · COMPLETED

Trial details

NCT number: NCT01259856
Sponsor: Ronald Hoffman
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

High Risk Polycythemia Vera High Risk Essential Thrombocythemia

Start date: 2011-09-01
Primary completion: 2017-06-30
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.